Select Page

Research & Activities

Get Started

Summary of Investigator-Initiated Research (1994-present)

have designed and conducted multiple research studies that have focused on

  • access to care, wait times, resource utilization
  • acute coronary syndromes
  • health outcomes in Canada and USA
  • processes of care
  • heart disease in South Asians
  • Disparities in care for visible minorities

Summary of Other Research Activities (1994-present )

  • consulted for Takeda –designing chronic angina trial(EXERT)
  • consulted for Glock –designing cholesterol absorption trial (G-PUR)
  • Steering Committee –SPRINT-AF study, CCRN, Canada
  • Steering Committee –CLASS ACT study, CCRN, Canada
  • Steering Committee –REACT study, CCRN, Canada
  • Journal Reviewer –American Heart Journal
  • Journal Reviewer –American Journal of Cardiology
  • Journal Reviewer –Canadian Medical Association Journal
  • Journal Reviewer –Journal of The American Medical Association
  • Abstract Reviewer –Canadian Cardiovascular Society meeting
  • Abstract Reviewer –American Heart Association meeting

Summary of Research Publications (1993 -present)

Peer-Reviewed Articles

    • Singh N, Thomson L, Goldstein MB, Langer A. ST Segment Shift in Hemodialys is Patients. Journal of Ambulatory Monitoring1993:6;155-162.
    • Singh N, Langer A, Freeman MR, Goldste in MB. Myocardial Alterations during Hemodialysis; Insights from New Noninvasive Technology. American Journal of Nephrology,1994;14:173-181
    • Langer A, Singh N, Freeman MR,Tibshirani R, Armstrong PW. Detection of silent ischemia adds to prognostic value of coronary anatomy and left ventricular function in predicting outcome in patients with unstable angina. Canadian Journal of Cardiology, 1995 II:2; 117-122.
    • Singh N, Langer A.Current status of silent myocardial ischemia. Canadian Journal of Cardiology, 1995 II: 4; 286-289.
    • Singh N, Mironov D, Goodman S, Morgan CD, Langer A. Treatment of silent ischemia in unstable angina: A randomized comparison of sustained-release verapamil versus metoprolol. Clinical Cardiology, 1995; 18:653-658.
    • Singh N, Daly PA, Gemmell CH, Yeo EL. Assessment of platelet activation in unstable angina: Value of micro particle generation measurements using flow cytometry. Canadian Journal of Cardiology,1995; 11 (11): 1015-1021.
    • Singh N, Mironov D, Ross AM, Armstrong PW, Langer A. Heart rate variability assessment early after acute myocardial infarction: Pathophysiologic and prognostic correlates. Circulation,1996; 93:1388-1395.
    • Singh N, Kuganesan K, Goode E, Ricci AJ. on behalf of the Cardiac Care Program. The Effect of Early Ambulation on Hematoma Formation and Vascular Complications Following 7 French Diagnostic Cardiac Catheterization. Canadian Journal of Cardiology 1998; 14(10):1223-1227.
    • Singh N, Gupta M, Fell D, Gangbar E. Impact and Inequity of inpatient waiting times for advanced cardiovascular services in community hospitals across the Greater Toronto Area. Canadian Journal of Cardiology 1999 ;15(7):777-782.
    • Gupta M, Doobay A, Singh N, Raja F, Mawji F, Karvetian A, Anand S, Yusuf S. A comparison of risk factors for and prognosis after acute myocardial infarction in South Asians and European Canadians. Can Med Assoc Journal 2002;166(6),717-722
    • Gillis AM, Philippon F, Cassidy MR, Singh N, Dorian P, Love BA, Kerr. Guidelines for implantable cardioverter defibrillator follow-up in Canada: A consensus statement of the Canadian Working Group on Cardiac Pacing. Canadian Journal of Cardiology 2002;19(1):21-28.
    • Ross H, Hendry P, Dipchand A, Giannetti N, Hirsch G, Issac D, Singh N, West L, White M. 2001 Canadian Cardiovascular Society Concensus Conference on Cardiac Transplantation. Canadian Journal of Cardiology 2003;19(6):620-635.
    • Singh N, Gupta M. Clinical Characteristics of South Asian patients hospitalized with heart failure. Ethnicity and Disease.2005;15(4):615-619
    • Gupta M, Singh N, Verma S. South Asians and Cardiovascular Risk. What Clinicians Should Know. Circulation. 2006: 113:924-92
    • Banerjee A, Gupta M, Singh N. Patient Characteristics, Compliance and Exercise Outcomes of South Asians Enrolled in Cardiac Rehabilitation. J Cardiopulmonary Rehabilitation and Prevention 2007;27, 212-218.
    • Gupta M, Singh N, Tsigoulis M, Kajil M, Hirjikaka S, Quan A, Teoh H, Verma S Perceptions of Canadian Primary Care Physician Towards Cardiovascular Risk Assessment and Lipid Management Canadian Journal of Cardiology 2012:28, 14-19
    • Gupta M. Singh N, Impactful Clinical Trials of 2012: What Clinicians Should Know.Canadian Journal of Cardiology 29 (2013)747-750
    • Abi-Samra FM, Singh N, Assi NA, Rosin BL, Dwyer JV, Miller CD for the CLEAR Investigators. Effect of Rate-Adaptive Pacing on Performance and Physiological Parameters during Activities of Daily Living: Results from the CLEAR (Cylos Responds with Physiological Rate Changes during Daily Activities) Study Europace 2013 Jun:15(6): 849-56
    • Gupta M , Ha A, Cox J, Dorian P, Fournier C, Gladstone D J, Lockwood E, Mancini J, Saldanha C, Shuaib A, Singh N, Kajil M , Tsigoulis M, Verma S. Patterns of oral anticoagulant use for stroke prevention in contemporary Canadian atrial fibrillation practice -insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry Canadian Journal of Cardiology; May 03, 2015, Vol32(2), 204-210
    • Gupta M, S zmitko PE, Singh N, T sigoulas M, Kajil M, Stone J. Management and control of Uncomplicated Hypertension in Canada: Insight from the Primary Care Audit of Global Risk Management (PARADIGM) Study Canadian Journal of Cardiology 31(2015)664-670
    • Law TK, Yan AT, Gupta A, Kajil M, T sigoulis M, Singh N, Verma S,Gupta M. Primary Prevention of Cardiovascular Disease: Global Cardiovascular Risk Assessment and Management in Clinical Practice.European Heart Journal –Quality of Care and Clinical Outcomes, Volume 1, Issue 1,July 2015, 31-36
    • Gupta M, S zmitko P, Singh N, T sigoulis M, Kajil M, StoneJ. Management and Control of Uncomplicated Hypertension in Canada: Insight from the Primary Care Audit Of Global Risk Management (PARADIGM) Study; Canadian Journal of Cardiology; May 2015, Vol. 31(5), 664-670
    • Ha A, Singh N, Cox J, Mancini J, Dorian P, Fournier C, Gladstone DJ, Lockwood E, Shuaib A, Kajil M, Tsigoulis M, Gupta M. Oral Anti coagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry Canadian Journal of Cardiology 32(2016)204-210
    • Gupta M, Kajil M, Tsigoulis M, Verma S, Singh N. Audit of Cardiovascular Risk Assessment and Lipid Management in Canadian Primary Care Physicians. Curr Res Cardiol 2016:3(2):33-37
    • Singh N, Gupta M. Impactful Clinical Trials of 2015: What Clinicians Should Know.Canadian Journal of Cardiology 32 (2016) 1038 e17-e20
    • Gupta M, Paul S, Kajil M, Ostrovski L, Tsigoulis M, Verma S, Singh N. Acetylsalicilic acid use in primary prevention in Canada: Insight from the primary care audit of global risk management (PARADIGM) study. Curr Res Cardiol. 2016,3(3):67-70
    • Stuckey T, Gammon R, Goswami R, Depta J, Steuter J, Meine F, Roberts M, Singh N, Ramchandani S, Burton T, Grouchy P, Khosousi A, Shad forth I, Sanders W. Cardiac Phase Space Tomography: A novel method of assessing coronary artery disease utilizing machine learning PLo S ONE 2018 13(8): e0198603. https://doi.org/10.1371/journal.pone.0198603
    • Alothman L, Zawadka M, A ljenedil S, Kajil M, Bewick D, Gaudet D, Hegele R, Lonn E, Ngui D, Ruel I, Tsigoulis M, Singh N, Genest J, Gupta M. Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm. Canadian Journal of Cardiology Volume 1, issue4, July 2019, Pages 190-197.
    • Ridker P, Everett B, Pradhan A, Mac FadyenJ, Solomon D, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber S, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med 2019; 380:752-762
    • Alothman L, Zawadka M, Aljenedil S, Kajil M, Bewick D, Guadet D, Hegele R, Lonn E, Ngui D. Ruel I, Tsigoulis M, Singh N, Genest J, Gupta M. Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm CJC Open 1(2019) 190-197
    • Bhavnani S, Stuckey T, Ramchandani S, Cohoon T, Khedraki R, Gammon R, Steuter J, Kaul P, Depta J, Meine F, Singh N, Burton T, Gilins H, Khosousi A, Shadforth I, Shen C, Sanders Jr W. Prospective clinical validation of a machine learning cardiac-phase-space analytic approach to predict coronary artery disease at the point-of-care. Submitted 2020. In Press.

Published Abstracts

  • Singh N, Thomson L, Goldstein MB, Langer A. Detection of ST Segment Shift in Hemodialysis Patients; A Possible Link to High Cardiovascular Mortality in End-Stage Renal Disease. Journal of the American College of Cardiology 1992; 19(3): 390A
  • Singh N, Langer A, Hsia T, Thomson L, Goldstein MB, Freeman MR. On-Line Assessment of Left Ventricular Function in End Stage Renal Disease: New Evidence for Myocardial Ischemia During Hemodialysis. Canadian Journal of Cardiology 1992; 8(Suppl. B): 81B
  • Singh N, Langer A, Freeman MR, Goldstein MB.Perfusion Defects in Hemodialysis Patients: Correlation with on-line ST-segment Analysis. Canadian Journal of Cardiology 1993; 9(Suppl. E): 127E
  • Singh N, Daly PA, Gemell C, Yeo EL. Platelet Activation in Acute Coronary Syndromes: Assessment Using Dual Label Flow Cytometry. Canadian Journal of Cardiology 1993; 9(Suppl. E): 74E. Circulation 1993; 88 (suppl): I-516
  • Singh N, Cox JL, Naylor CD, Brophy J, Langer A. Regional Variations in Resource Utilization and Outcomes Post MICanadian Journal of Cardiology 1994; 10(Suppl. C): 87C.
  • Singh N, Cox J, Naylor CD, Brophy J, Armstrong PW, Langer A. Outcomes of Acute MI Presenting at University vs Community Hospitals: The GUSTO Canadian Experience.Canadian Journal of Cardiology 1994; 10(Suppl. C): 98C.Circulation 1994; 90 (suppl): I-325
  • Singh N, Mironov D, Goodman S, Morgan CD, Langer A. Treatment of Silent Ischemia in Unstable Angina: A Randomized Comparison of Isopt in SR Versus Metoprolol. Canadian Journal of Cardiology 1994; 10(Suppl. C): 130C.Journal of the American College of Cardiology 1995; 25Suppl A: 88A
  • Singh N, Mironov D, Ross AM, Armstrong PW, Langer A. Heart-Rate Variability During the First 48 Hours Post Infarction: GUSTO Angiographic and Clinical Correlates. Canadian Journal of Cardiology 1994; 10(Suppl. C): 111C. Circulation 1994; 90 (suppl): I-274.
  • Singh N, Ricci AJ for the Cardiac Care Committee, Centenary Health Centre. An Integrated Approach to Optimizing Effectiveness of Acute Myocardial Infarction (AMI) Management in the Community. Clin Invest Med 1996; 19(4); S7.
  • Singh N, Kuganesan K, Goode E, on behalf of the Cardiac Care Program. The Effect of Early Ambulation on Hematoma Formation and Vascular Complications Following 7 French Diagnostic Cardiac Catheterization.Canadian Journal of Cardiology 1997; 13 (suppl C):104C.
  • Gupta M, Singh N, Gangbar E, Fell D. Inequity of Access to Inpatient Coronary Angiography in Greater Toronto Area (GTA) Community Hospitals Canadian Journal of Cardiology 1998; 14 (suppl F):132F
  • Singh N, Gupta M, Gangbar E, Fell D. Impact of In-Patient Waiting Times for Advanced Cardiovascular (CV) Services in Greater Toronto Area (GTA) Community Hospitals Canadian Journal of Cardiology 1998; 14(suppl F):115F
  • Gupta M, Singh N, Raja F, Mawji F, Doobay A, Anand S, Yusuf S. A comparison of risk factors for and prognosis after acute myocardial infarction in South Asians and European Canadians. Canadian Journal of Cardiology 1999; 15(suppl D):105D
  • Singh N, Gupta M. Physician Resources and Threshold Caps Key Determinants of Prolonged Waits to see Cardiologists in Greater Toronto Area (GTA). Canadian Journal of Cardiology 1999; 15(suppl D):171D
  • Singh N, Gupta M. Temporal trends in in-patient waiting times and outcomes for advanced cardiovascular services in Greater Toronto Area (GTA) community hospitals. Canadian Journal of Cardiology 2000; 16(suppl F):148F
  • Singh N, Gupta M. Jain A, Halperin D, Borts D.Differences in presentation and 1 yr outcomes in coronary artery disease(CAD) patients of South asian vs European Ethnicity Treated in an Outpatient Cardiology Practice Journal of the American College of Cardiology 2001;37(suppl D):171D
  • Singh N, Gupta M, Biswas T, Nquyen QM, Ali K. Impact on South Asian Ethnicity On Presentation and Outcomes with Hospitalization for Congestive Heart Failure.Canadian Journal of Cardiology2001;17(supp C):60C. Journal of the American College of Cardiology2001; 39(suppl A): 193A
  • Gupta M, Singh N, Warsi M, Reiter N, Ali K. Canadian South Asians have more Severe Angiographic Coronary Disease than European Canadians Despite having fewer risk factors Canadian Journal of Cardiology2001;17 (suppC):68C
  • Gupta M, Singh N, Canadian Women of South Asians Origin are twice as likely to have Left Main Or 3-Vessel Coronary Disease as Women of European Origin.Canadian Journal of Cardiology2001;17(supp C):71C
  • Singh N, Gupta M, Janmohamed A, Dorian P. Who needs and Implantable Defibrillator (ICD), Considerable Inconsistency among Cardiologists despite National Consensus Guidelines, Journal of the American College of Cardiology2002; 39(suppl B): 212B
  • Singh N, Gupta M, Ricci AJ, Bopari S, Malik K,Significant Differences in Risk Factors, Compliance, and Exercise Outcomes Identified In South Asian Cardiac Rehabilitation Patients Canadian Journal of Cardiology2002; 18(supp B):220B
  • Singh N, Santa M, Van Crisco L, Significant time delays in transfer for primary PCI versus on-site thrombolysis for STEMI patients in an urban American community hospital. Canadian Journal of Cardiology2004;20 (supp D):123D
  • Singh N, Prabakaran K, Crisco LV,Baig F, Mc Callister T. Low level exercise with adenosine infusion improves image quality, symptom tolerance and arrhythmias during nuclear myocardial perfusion studies Canadian Journal of Cardiology2005
  • Prabakaran K, Singh N. Effect of Low level Exercise with Adenosine on Septal Perfusion in LBBB. Journal of Nuclear Medicine2006; 47:5 (Maysuppl): 535P
  • Gupta M, Singh N, Teoh H, Yi Q, Strauss M, Tsigoulis M, Verma S, Eikelboom J. Fibrinolytic Function In South Asians And Europeans With Coronary Heart Disease: Insights From The Practice Registry Canadian Journal of Cardiology 2010
  • Singh N, Kaleka P, Patel P, Patel R, Balk M.Office Based Measurement Of Waist And Hip Circumference By Cardiologists Does Not Translate Into Improved Subsequent Measurements Or Reduced Weight Journal of the American College of Cardiology April 2011
  • Vaccari D, Alvarenga C, Jesus I, Layher J, Takahashi A, Singh N, Siot P, E lkaim JP. Results of a large prospective registry of pacemaker patients programmed with minimized ventricular pacing algorithm:even minimized, ventricular pacing remains a significant predictor of AF occurrence. Europace 2011
  • Singh N, Kaleka P, Chandra S, Song D, Yan L, Suh D, Dorsey A, Ramamurthy S Ethnic Differences in Patient Characteristics, But Not Implantable Cardioverter-Defibrillator (ICD) Utilization Rates for Primary Prevention of Sudden Cardiac Death (SCD) Canadian Journal of Cardiology 2011, Circulation 2011
  • Singh N, Hall E, Lucas E, Chandra S, Song D, Yan L, Suh D, Dorsey A, Ramamurthy S Potential Primary Prevention Implantable Cardioverter-Defibrillator (ICD) Patients Lack Understanding, Want More Information and are Willing to Reconsider Implant Refusal.Canadian Journal of Cardiology Oct 2012, Circulation 2012
  • Saha D, Tsigoulis M, Verma S, Singh N, Gupta A, Gupta M. Prevalence of Risk Factors and Occult Coronary Disease in South Asians Referred to a Specialized Risk Assessment Clinic Canadian Journal of Cardiology Oct 2012
  • Gupta, A., Kajil, M., Singh, N., Tsigoulis, M. Verma, S., Gupta, M.Variability in traditional and novel cardiovascular risk factors by ethnic origin: Insights from the primary care audit of global risk management (PARADIGM) study. AHA 2012
  • Singh N, Amin A, Chandra S, Song D, Yan L, Suh D Significant Difference in Appropriate Use Criteria (AUC) Score for Outpatient SPECT Myocardial Perfusion Imaging (MPI) based on Age, Gender, Ethnicity, Site and Ordering Physician. (JACC 2013)
  • Gupta M, Kajil M, Tsigoulis M, Singh N, Verma S. –Prevalence of Chronic Kidney Disease (CKD) in Non-Diabetic Middle-AgedAdults: Insight from the PARADIGM Study CCS 2013
  • Gupta M, Kajil M, Tsigoulis M, Bansal A, Hirjikaka S, Singh N, Verma S. –Adherence to Evidence based medications in South Asian and white Caucasian patients with coronary heart disease: Insight from the PRACTICE Study CCS 2013
  • Singh N, Premji S, Chandra S, Song D, Yan L , Suh D. Suboptimal Time in Therapeutic Range (TTR) for International Normalized Ratio (INR) measurements observed in an outpatient cardiology clinic : Impact of Gender, Ethnicity, Disease Etiology, CHADSV asc score , Physicians and Clinic site. Canadian Journal of Cardiology Oct 2013
  • Singh N, MCMunn J, Chandra S, Song D, Yan L , Suh D. Multiple factors may contribute to physician variability in Appropriate Use Criteria (AUC) scores for Myocardial Perfusion imaging (MPI) Canadian Journal of Cardiology Oct 2013
  • Gupta M, Ha A, CoxJ, Dorian P, Fournier C, Gladstone D J, Lockwood E, Mancini J, Saldanha C, Shuaib A, Singh N, Kajil M , Tsigoulis M, Verma S. Factors Associated with New Oral Anticoagulant versus Vitamin K Antagonist Use in a Contemporary, National, Real-World Observational Registry: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (ACC 2014)
  • Gupta M , Ha A, Cox J, Dorian P, Fournier C, Gladstone DJ, Lockwood E, Mancini J, Saldanha C, Shuaib A, Singh N, Kajil M , Tsigoulis M, Verma S. Disagreement between Physician-Reported and Scoring System-Based Stroke and Bleeding Risks in Patients with Atrial Fibrillation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (ACC 2014)
  • Ha AC, Singh N, CoxJ L, Dorian P, Fournier C, Mancini GBJ, Shuaib A, Kajil M, Tsigoulis M, Gupta MK. Is Accurate Stroke Risk assessment with CHADS2Necessary in Managing Patients with Atrial Fibrillation? Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (CCS and AHA 2014)
  • Gupta MK, Singh N, Cox JL, Dorian P, Fournier C, Mancini GBJ, Shuaib A, Kajil M, Tsigoulis M, Ha AC High Rates of antiplatelet Use in Atrial Fibrillation Patients Treated With Oral Anti coagulation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (CCS and AHA 2014)
  • Singh N, Dubal P,Turner K,Adams H, Chandra S, Song D, Yan L , Suh D. Ranolazine, Ethnicity and the metabolic syndrome (REMS) study: A pilot study showing the differential effects amongst Caucasians, African Americans, and Asians in exercise tolerance time (ETT) and glycemic control but not angina scores. (ADA and ESC 2014)
  • Law, T.K., Yan, A.T., Tsigoulis, M., Kajil, M., Verma, S., Singh N., Gupta, M. Gender-Related Differences in Cardiovascular Risk Assessment and Management in Primary Care: Insights from the Primary Care Audit of Global Risk Management (PARADIGM) Study CCC 2014
  • Ha, A., Singh N., Tsigoulis, M., Kajil, M., Verma, S., Cox, J., Dorian, P., Fournier, C., Gladstone, D., Lockwood, E., Mancini G., Saldanha, C., Shuaib, A., Tsigoulis, M., Gupta, M. The influence of stroke and bleeding risk on oral anticoagulant use for stroke prevention in patients with atrial fibrillation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) registry CCC 2014
  • Singh N, Dubal P, Jain N, Chandra S, Song D, Yan L , Suh D. Sub optimal Adherence to Evidence Based Coronary Artery Disease (CAD) Therapy: Impact of Gender, Ethnicity, Prescribing Physician and Drug Intolerance. Canadian Journal of Cardiology 2014
  • Gupta MK, Singh N, T sigoulis M, Kajil M, Cox JL, Dorian P, Mancini GBJ, Ha AC . Underuse of Full Dose Factor Xa Inhibition in Atrial Fibrillation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (ACC 2015)
  • Kaushal A, Kajil M, Tsigoulis M, Gill S, Singh N, Yan AT, Gupta M. The Risk of Obstructive Sleep Apnea in a healthy, middle aged North American population: Insights from the PARADIGM study. Canadian Journal of Cardiology 2015
  • Foltz T, Singh N, S Chandra S, Song D, Yan L , Suh D. Higher Chadsvasc Scores But Similar Complication And Mortality Rates In Women With Atrial Fibrillation Over 1 Year In An Outpatient Cardiology Setting AHA 2016
  • Gupta M, Kajil M, Tsigoulis M, Dhillon P, Cox J, Dorian P, Fournier C, Gladstone D, Lockwood E, Mancini J, Shuaib A, Singh N, Ha A.Sex Differences In Stroke Risk Profile, Stroke Prevention Therapy Use And Treatment Satisfaction In A Contemporary Cohort Of Patients With Atrial Fibrillation: Insights From SPRINT-AF AHA 2016
  • Ha A, Kajil M, Tsigoulis M, Dhillon P, Cox J, Dorian P, Fournier C, Gladstone D,Lockwood E, ManciniJ B, Shuaib A, Singh N, Gupta M.Patterns of anti thrombotic use in relation to the CHA2DS2-VASC and the CHADS2-65 stroke risk score in contemporary practice: Insights from a prospective Canadian atrial fibrillation (SPRINT-AF) registry. CCC 2016
  • Shuaib A,Ha A, Kajil M, Tsigoulis M, Co xJ, DorianP, Fournier C, Gladstone D, Lockwood E, ManciniJ, Singh N, Gupta M. A cross Canada assessment of management of patients with a history of TIA or stroke related to atrial fibrillation. Insights from SPRINT-AF registry CSA 2016
  • Ha A, Wu Y, Kajil M, Tsigoulis M, Dhillon P, Cox J, Dorian P, Fournier C, Gladstone D, Lockwood E, ManciniJ, Shuaib A, Singh N, Gupta M. Concomitant use of anti platelet and oral anti coagulation among patients with atrial fibrillation: Insights From SPRINT-AF ACC 2017
  • Crawford S, Burton T, Sander Jr WE. Coronary Artery Disease Learning and Algorithm Development Study (CADLAD): Early Analysis of Ejection Fraction Evaluation. ACC 2017
  • Foltz T, Singh N, S Chandra S, Song D, Yan L , Suh D. Marked Physician Variability in Oral Anticoagulant Treatment Choices Reflect Significant Differences in Atrial Fibrillation Patient Characteristics ACC 2017
  • Gupta M, Labos C, Kajil M, Tsigoulis M, Cox J, Dorian P, Mancini G.B.J, Fournier C, Gladstone D, Lockwood E, Shuaib A, Singh N, Ha A. Which factors influence the choice of a non vitamin K oral anticoagulant over warfarin for stroke prevention among atrial fibrillation patients? Insights from the prospective SPRINTA Fregistry ESC 2017
  • Jayaprakash H.K, Labos C, Shuaib A, Kajil A, Tsigoulis M, Cox J, Dorian P, Mancini G.B.J, Fournier C, Gladstone D, Lockwood E, Singh N, Ha A, Gupta M. Do atrial fibrillation patients with history of cerebrovascular accidents receive guideline concordant stroke preventive therapies? Insights from the prospective SPRINTAF registry ESC 2017
  • Ha A, Kajil M, Tsigoulis M, Labos C, CoxJ, Dorian P, Mancini G.B.J, Fournier C, Gladstone D, Lockwood E, Shuaib A, Singh N, Gupta M. Anti thrombotic use amongst patients at low stroke risk as defined by the CHA2DS2VASc score: Insight from the prospective SPRINTAF registry ESC 2017
  • Labos C, Ha A, Kajil M, Tsigoulis M, Cox J, Dorian P, Mancini J, Gladstone D, Lockwood E, Shuaib A, Sikri H, Singh N, Gupta M. Appropriateness of non-vitamin K oral anticoagulant dosing among Canadian atrial fibrillation patients CCC 2017
  • Gupta M, Ha A, Kajil M, Tsigoulis M, Cox J, Dorian P, Mancini J, Gladstone D, Lockwood E, Shuaib A, Singh N, Labos C. Adequacy of hypertension control among patients with atrial fibrillation at high cardiovascular risk: Insights from a Canadian prospective registry AHA 2017
  • Labos C, Ha A, Kajil M, Tsigouls M, Cox J, Dorian P, Mancini J, Gladstone D, Lockwood E, Shuaib A, Sikri H, Singh N,Gupta M. Rates and patterns of inappropriate dosing for non-vitamin K oral anticoagulant among Canadian atrial fibrillation patients: Insights from a prospective registry AHA 2017
  • Stuckey T, Singh N, Goswami R, Depta J, Gammon R, Roberts M, SteuterJ, Gupta S, Sanders WJR. Assessing CAD by Cardiac Phase Tomography Using Machined Learned Algorithms in Obese and Elderly TCT 2017
  • Stuckey T, Singh N, Goswami R, Depta J, Gammon R, Roberts M, Steuter J, Gupta S, Sanders W JR. Gender based Assessment of CAD by Cardiac Phase Tomography Using Machine-Learned Algorithms TCT 2017
  • Ha A, Labos C, Kajil M, Tsigoulis M, Cox J, Dorian P, Mancini G.B, Gladstone D, Lockewood E, Shuaib A, Chan W, Singh N, Gupta M.What factors influence the choice of Apixaban, Rivaroxaban, or Dabigatran for stroke prevention among atrial fibrillation. ACC 2018
  • Labos C, Ha A, Dorian P, Tsigoulis M, Kajil M, Cox J, Mancini G, Gladstone D, Lockwood E, Shuaib A, Singh N, Gupta M.Persistence of oral anti goagulent use among Canadian atrial fibrillation patients: One-year results from the prospective SPRINT-AF registry CCC 2018
  • Lonn E, Ngui D, RuelI, Singh N, Genest J. The high prevalence of familial hypercholesterolemia in a population of ASCVD patients with LDL-C above target: an analysis from the REACT registry CCC 2018
  • Singh N, Premji S, RamakrishnanD. Significant underutilization of angiotensin receptor neprolysin inhibitor (ARNI) and other evidence-based heart failure (HF) therapies in an outpatient clinic setting. ESC HF 2019
  • Ha A,Labos C,Dorian P,Mancini J,Cox J, Gladstone D, Lockwood E, Singh N, Shuaib A, Padarath M, Gupta M. Factors Associated with Changes With Impaired Quality of Life Among Atrial Fibrillation Patients in Real-world ClinicalPractice: InsightsFrom the Prospective Canadian SPRINT-AF RegistryAHA 2019 CCC 2019

Connect With Us